(S (NP (NNS Tumors)) (VP (VP (VBP are) (ADJP (RB extremely) (JJ heterogeneous))) (CC and) (VP (NN comprise) (PP (IN of) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (JJ intratumor) (NNS microenvironments) (CC or) (NNS sub-regions))))))) (. .))
(S (NP (DT These) (NN tumor) (NNS microenvironments)) (VP (MD may) (VP (VB interact) (PP (IN with) (NP (NNS eac))) (PP (VBN based) (PP (IN on) (NP (NP (JJ complex) (JJ high-level) (NNS relationships)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD could) (VP (VB provide) (NP (NP (JJ important) (NN insight)) (PP (IN into) (NP (NP (DT the) (JJ organizational) (NN structure)) (PP (IN of) (NP (DT the) (NN tumor) (NN network))))))))))))))) (. .))
(S (PP (TO To) (NP (DT that) (NN end))) (, ,) (NP (PRP we)) (VP (VBD developed) (NP (NP (DT a) (NN tumor) (NNS connectomics) (NN framework)) (PRN (-LRB- -LRB-) (NP (NNP TCF)) (-RRB- -RRB-)) (SBAR (S (VP (TO to) (VP (VB understand) (CC and) (VB model) (NP (NP (DT the) (JJ complex) (ADJP (NN functional) (CC and) (JJ morphological)) (NNS interactions)) (PP (IN within) (NP (DT the) (NN tumor)))))))))) (. .))
(S (ADVP (RB Then)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (NP (NP (NP (DT the) (NNP TCF) (POS 's)) (NN potential)) (PP (IN in) (S (VP (VBG predicting) (NP (NN treatment) (NN response)) (PP (IN in) (NP (NP (NN breast) (NN cancer) (NNS patients)) (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (JJ neoadjuvant) (NN chemotherapy)))))))))))) (. .))
(S (NP (DT The) (NNP TCF)) (VP (VBD was) (VP (VBN implemented) (PP (IN on) (NP (NP (DT a) (NN breast) (NN cancer) (JJ patient) (NN cohort)) (PP (IN of) (NP (NP (JJ thirty-four) (NNS patients)) (PP (IN with) (NP (NP (ADJP (JJ dynamic) (NN contrast) (VBD enhanced)) (PRN (-LRB- -LRB-) (NNP DCE) (-RRB- -RRB-)) (JJ magnetic) (NN resonance) (NN imaging)) (PRN (-LRB- -LRB-) (NP (NNP MRI)) (-RRB- -RRB-)))) (VP (VBG undergoing) (NP (JJ neodjuvant) (NN chemotherapy) (NN treatment))))))))) (. .))
(S (NP (NP (DT The) (JJ intra-tumor) (NN network) (NNS connections)) (PRN (-LRB- -LRB-) (NP (VB tumor) (NN connectome)) (-RRB- -RRB-)) (PP (IN before) (CC and) (IN after) (NP (NN treatment)))) (VP (VBD were) (VP (VBN modeled) (S (VP (VBG using) (NP (NP (JJ advanced) (NX (NN graph) (JJ theoretic) (NX (NN centrality))) (, ,) (NX (NN path) (NN length)) (CC and) (NX (VBG clustering) (NNS metrics))) (PP (IN from) (NP (DT the) (NNP DCE-MRI)))))))) (. .))
(S (NP (NP (DT The) (NN percentage) (NN change)) (PP (IN of) (NP (DT the) (NN graph) (NNS metrics))) (PP (IN between) (NP (NP (CD two) (NNS time-points)) (PRN (-LRB- -LRB-) (NP (NP (NNP Baseline)) (CC and) (NP (CD 1st) (NN cycle))) (-RRB- -RRB-))))) (VP (VBD was) (VP (VBN computed) (S (VP (TO to) (VP (VB predict) (NP (NP (NP (DT the) (NN patient) (POS 's)) (JJ final) (NN response)) (PP (TO to) (NP (NN treatment))))))))) (. .))
(S (NP (DT The) (NNP TCF)) (VP (VP (VBD visualized) (NP (DT the) (JJ inter-voxel) (NN network) (NNS connections)) (PP (IN across) (NP (JJ multiple) (NNS time-points)))) (CC and) (VP (VBD was) (ADJP (JJ able) (S (VP (TO to) (VP (VB evaluate) (NP (NP (JJ specific) (NNS changes)) (PP (IN in) (NP (DT the) (NN tumor) (NN connectome))) (PP (IN with) (NP (NN treatment)))))))))) (. .))
(S (NP (NNP Degree) (NN centrality)) (VP (VBD was) (VP (VBN identified) (PP (IN as) (NP (NP (DT the) (ADJP (RBS most) (JJ significant)) (NN predictor)) (PP (IN of) (NP (NN treatment) (NN response))) (PP (IN with) (NP (NP (DT an) (NNP AUC)) (PP (IN of) (NP (CD 0.83))))))) (PP (IN for) (S (VP (VBG classifying) (NP (NNS responders)) (PP (IN from) (NP (NNS non-responders)))))))) (. .))
(S (PP (IN In) (NP (NN conclusion))) (, ,) (NP (DT the) (NNP TCF) (NN graph) (NNS metrics)) (VP (VBD produced) (NP (NP (JJ excellent) (NNS biomarkers)) (PP (IN for) (NP (NP (NN prediction)) (PP (IN of) (NP (NN breast) (NN cancer) (NN treatment) (NN response)))))) (PP (IN with) (NP (NP (JJ improved) (NN visualization) (CC and) (NN interpretability)) (PP (IN of) (NP (NP (NNS changes)) (ADVP (DT both) (RB locally) (CC and) (RB globally)) (PP (IN in) (NP (DT the) (NN tumor)))))))) (. .))
